Recombinant vector for coding chimeric coronavirus spike protein and application thereof
The present invention provides a recombinant vector encoding a chimeric coronavirus spike protein. The invention further provides novel immunogenic compositions and vaccines comprising these recombinant vectors. Also included are methods of administering these immunogenic compositions and vaccines to animal subjects, including humans, felines, and poultry, to protect them against coronavirus. Methods of making immunogenic compositions and vaccines, alone or in combination with other protective agents, are also provided..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 01. Sept. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
LANGEREIS MARK A [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-09-01, Last update posted on www.tib.eu: 2023-11-21, Last updated: 2023-11-24 |
|---|
| Patentnummer: |
CN116685347 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018589138 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018589138 | ||
| 003 | DE-627 | ||
| 005 | 20231124100606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231124s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018589138 | ||
| 035 | |a (EPA)CN116685347 | ||
| 035 | |a (EPA)75362394 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a LANGEREIS MARK A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recombinant vector for coding chimeric coronavirus spike protein and application thereof |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-09-01, Last update posted on www.tib.eu: 2023-11-21, Last updated: 2023-11-24 | ||
| 520 | |a The present invention provides a recombinant vector encoding a chimeric coronavirus spike protein. The invention further provides novel immunogenic compositions and vaccines comprising these recombinant vectors. Also included are methods of administering these immunogenic compositions and vaccines to animal subjects, including humans, felines, and poultry, to protect them against coronavirus. Methods of making immunogenic compositions and vaccines, alone or in combination with other protective agents, are also provided. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a DE GROOF AD |4 aut | |
| 700 | 0 | |a VERMEIJ PAUL |4 aut | |
| 700 | 0 | |a BOSCH BEREND JAN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 01. Sept. |
| 773 | 1 | 8 | |g year:2023 |g day:01 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/75362394/publication/CN116685347A1?q=CN116685347 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 01 |c 09 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 01 |c 09 | ||